mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |